Cite
MLA Citation
R Velasco et al.. “P10.04 Incidence and characteristics of neurological adverse events secondary to immunotherapy with checkpoint inhibitors.” Neuro-oncology, vol. 21, n.d., p. iii41. http://access.bl.uk/ark:/81055/vdc_100109737238.0x000016